China (Mainland)
Low price Linezolid with high purity CAS NO.165800-03-3
- FOB Price: USD: 1.00-5.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Available Specifications:
1(31-50)Kilogram1(21-30)Kilogram2(11-20)Kilogram3(1-10)Kilogram
- Product Details
Keywords
- Linezolid
- Linezolid and InterMediate
- Linezolid (200 mg)
Quick Details
- ProName: Low price Linezolid with high purity
- CasNo: 165800-03-3
- Molecular Formula: C16H20FN3O4
- Appearance: White Crystalline Powder
- Application: Pfizer compounds;TYGACIL;Antibacterial...
- DeliveryTime: ASAP / Prompt upon the Payment terms
- PackAge: Customized
- Port: Qingdao,Shanghai, Tianjin
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: Cool and dry place
- Transportation: by sea, by air
- LimitNum: 1 Kilogram
- Moisture Content: 0.1
- Impurity: 0.01
- Assay: 99.95%
- MF: C16H20FN3O4
- MW: 337.35
- EINECS: 2017-001-1
Superiority
Henan CoreyChem Co., Ltd, based on the original Zhengzhou Cote Chemical Research Institute, be brave in absorbing highly educated talents & overseas returnees; actively responded to Zhengzhou City High-tech Zone Government’s Special Care Policy, reorganized and founded in National University of Science and Technology Park, which is a high-tech, stock enterprise of high-end chemical Custom synthesis;The park was created by the People's Government of Henan Province, and proved by Ministry of Education and the National Science & Technology, taking the construction mode of "many college a park, and common development", mainly depends on Zhengzhou University and Henan University’s scientific research and talent advantage to set up Universities, scientific research institute and enterprise scientific research achievements transformation platform, to make high-tech enterprises incubate, is the new high-tech talent gathering base, high and new technology industry enterprise radiation base, colleges and universities technological innovation base.
Henan Coreychem Co., Ltd, facing global High-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and Rare chemicals trade. Corey have well-equipped machine, strong technical force and considerate marketing team service. We also have rich experience advantage in basic research, small scale process development, scale-up, industrial technology development & production and cost control.
Details
| Linezolid Basic information |
| Product Name: | Linezolid |
| Synonyms: | Linezolid and InterMediate;N-{[(5S)-3-[3-fluoro-4-(Morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]Methyl}acetaMide;(S)-N-((3-(3-fluoro-4-Morpholinophenyl)-2-oxooxazolidin-5-yl)Methyl)acetaMide;Linezolid (PNU-100766);Linezolid API;Ray Nizzoli;Linezolid (S)-N-[[3-(3-Fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide;Linezolid (200 mg) |
| CAS: | 165800-03-3 |
| MF: | C16H20FN3O4 |
| MW: | 337.35 |
| EINECS: | 2017-001-1 |
| Product Categories: | Pfizer compounds;TYGACIL;Antibacterial;Aromatics Compounds;Aromatices;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;API |
| Mol File: | 165800-03-3.mol |
|
|
|
| Linezolid Chemical Properties |
| Melting point | 176-1780C |
| alpha | D20 -9° (c = 0.919 in chloroform) |
| storage temp. | Store at RT |
| solubility | DMSO: >20mg/mL |
| color | white to off-white |
| InChIKey | TYZROVQLWOKYKF-ZDUSSCGKSA-N |
| CAS DataBase Reference | 165800-03-3(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 36-24/25 |
| RTECS | AC2720000 |
| HS Code | 29419000 |
| Hazardous Substances Data | 165800-03-3(Hazardous Substances Data) |
| MSDS Information |
| Provider | Language |
|---|---|
| Linezolid | English |
| Linezolid Usage And Synthesis |
| Outline | Linezolid (U-100766, PNU-100766) developed and produced by the US Pharmacia & Upiohn company (which has been acquired by Pfizer) ,is a new type of azole oxazolidinone class of synthetic antibacterial drugs, the FDA on April 18, 2000 approved the drug to market. This product is the first drug in American in 40 years which is approved for the treatment of methicillin-resistant Staphylococcus aureus infection, September 2007 month in China's listed, it belongs to the Medicare B drugs. |
| Indications |
For the treatment of Gram-positive (G +) bacteria caused infections, including concurrent bacteremia; nosocomial pneumonia; community-acquired pneumonia ( because bacteria are not the same,pneumonia is clinically divided into hospital-acquired pneumonia and community-acquired pneumonia) and concomitant bacteremia; it can be applied for the complexity of the skin and skin and soft tissue infections, including osteomyelitis in diabetic foot infections; uncomplicated skin and skin and soft tissue infections; it is also used for the treatment of vancomycin-resistant feces enterococci. The above information is edited by the chemicalbook of Tian Ye. |
| Uses |
fully synthetic oxazolidinone antibiotics. oxazolidinone antibacterial drugs. anti-inflammatory drug. inhibit bacterial mRNA translation. |
| Chemical Properties | White Solid |
| Uses | Prototype of the oxazolidinone antimicrobials; inhibits bacterial mRNA translation. |
| Uses | antibacterial |
| Definition | ChEBI: An organofluorine compound that consists of 1,3-oxazolidin-2-one bearing an N-3-fluoro-4-(morpholin-4-yl)phenyl group as well as an acetamidomethyl group at position 5. A synthetic antibacterial agent that inhibits bacterial protein synt esis by binding to a site on 23S ribosomal RNA of the 50S subunit and prevents further formation of a functional 70S initiation complex. |
| Biological Activity | Oxazolidinone antibiotic. Inhibits bacterial protein synthesis prior to chain initiation. Displays potent antibacterial activity against a variety of multidrug-resistant gram-positive microbes in vitro and in vivo . |
